Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. [electronic resource]
Producer: 20070410Description: 515-26 p. digitalISSN:- 0028-3908
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Antiparkinson Agents -- adverse effects
- Disease Models, Animal
- Drug Administration Schedule
- Drug Interactions
- Dyskinesia, Drug-Induced -- drug therapy
- Haplorhini
- Levodopa -- adverse effects
- Male
- Models, Biological
- Nerve Tissue Proteins -- metabolism
- Oxidopamine
- Parkinson Disease, Secondary -- chemically induced
- Protein Kinase C -- metabolism
- Rats
- Rats, Sprague-Dawley
- Selective Estrogen Receptor Modulators -- therapeutic use
- Tamoxifen -- therapeutic use
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.